Quadrille Capital appeared to be the VC, which was created in 2007. The main office of represented VC is situated in the Paris. The company was established in Europe in France.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Quadrille Capital, startups are often financed by Norwest Venture Partners, Venrock, Windham Venture Partners. The meaningful sponsors for the fund in investment in the same round are Windham Venture Partners, Universal Music Group, Tudor Investments. In the next rounds fund is usually obtained by New Enterprise Associates, Windham Venture Partners, TPG Growth.
We also calculated 4 valuable employees in our database.
The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Intarcia Therapeutics, ezCater, Neotract. We can highlight the next thriving fund investment areas, such as Marketing, Manufacturing.
The high activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. This Quadrille Capital works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The average startup value when the investment from Quadrille Capital is more than 1 billion dollars. Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
Fund Name | Location |
Asch | - |
Beijing Trust&Far Technology | Beijing, Beijing Shi, China |
Bombora Group | - |
Catcha Group | Kuala Lumpur, Malaysia |
Compass Genetics Investors | Delaware, Dover, United States |
Corriente Advisors | Fort Worth, Texas, United States |
Devon Park BioVentures | Pennsylvania, United States, Wayne |
Dispatch | New York, New York, United States |
HubSpot | Cambridge, Massachusetts, United States |
Iceni Seedcorn Fund | Norfolk, Norwich, United Kingdom |
Marine Institute | Galway, Ireland, Oranmore |
Matrixport | Central, Central Region, Singapore |
Monttu Ventures | Finland, Southwest Finland, Turku |
NovX Capital | Latvia, Riga, Vidzeme |
Second City Capital | British Columbia, Canada, Vancouver |
Starwood Energy Group Global | Connecticut, Greenwich, United States |
Walter Ventures | Andalucia, Málaga, Spain |
Wemade Entertainment Co Ltd | Kyonggi-do, Seongnam, South Korea |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Medwing | $51M | 15 Mar 2023 | Berlin, Berlin, Germany | ||
Anyfin | $38M | 18 Jan 2023 | Stockholm, Stockholm County, Sweden | ||
Homa Games | $121M | 12 Oct 2022 | Paris, Ile-de-France, France | ||
BigHat Biosciences | $75M | 20 Jul 2022 | California, United States | ||
PlanRadar | $70M | 20 Jan 2022 | Vienna, Austria | ||
La Belle Vie | $29M | 15 Dec 2021 | Paris, Ile-de-France, France | ||
Anyfin | $52M | 05 Oct 2021 | Stockholm, Stockholm County, Sweden | ||
Rohlik | $118M | 01 Jul 2021 | Prague, Prague, Czechia | ||
Rohlik | $230M | 02 Mar 2021 | Prague, Prague, Czechia |
– Rohlik Group, a Prague, Czech Republic-based online grocery business, raised €190m in funding.
– The round was led by Partech, joined by Index Ventures, with participation from EBRD, J&T Banka, Quadrille Capital, R2G and existing investor Enern.
– The company intends to use the funds to accelerate its expansion in its existing markets and launch in Germany and other international markets and continue to invest in technology and operating capabilities.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Medwing | $51M | 15 Mar 2023 | Berlin, Berlin, Germany | ||
Anyfin | $38M | 18 Jan 2023 | Stockholm, Stockholm County, Sweden | ||
Homa Games | $121M | 12 Oct 2022 | Paris, Ile-de-France, France | ||
BigHat Biosciences | $75M | 20 Jul 2022 | California, United States | ||
PlanRadar | $70M | 20 Jan 2022 | Vienna, Austria | ||
La Belle Vie | $29M | 15 Dec 2021 | Paris, Ile-de-France, France | ||
Anyfin | $52M | 05 Oct 2021 | Stockholm, Stockholm County, Sweden | ||
Rohlik | $118M | 01 Jul 2021 | Prague, Prague, Czechia | ||
Rohlik | $230M | 02 Mar 2021 | Prague, Prague, Czechia |